Benedikt Steitz

Title: Benedikt Steitz: Innovator in Pharmaceutical Compositions

Introduction

Benedikt Steitz is a notable inventor based in Kallstadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Hepatitis C Virus (HCV). His innovative work has led to the development of a unique solid pharmaceutical composition that showcases his expertise and dedication to improving healthcare.

Latest Patents

Benedikt Steitz holds one patent titled "Solid pharmaceutical compositions for treating HCV." This invention features solid pharmaceutical compositions comprising Compound 1 and Compound 2. In one embodiment, the solid pharmaceutical composition includes a first layer that comprises 100 mg of Compound 1, along with a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all formulated in amorphous solid dispersion. Additionally, a second layer comprises 40 mg of Compound 2, also combined with a pharmaceutically acceptable hydrophilic polymer and surfactant, formulated in amorphous solid dispersion.

Career Highlights

Throughout his career, Benedikt Steitz has worked with prominent companies in the pharmaceutical industry. He has been associated with AbbVie Inc. and AstraZeneca U.K. Limited, where he has contributed to various projects and advancements in drug development.

Collaborations

Benedikt has collaborated with esteemed colleagues, including Nancy E. Sever and Ulrich Westedt. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Benedikt Steitz is a distinguished inventor whose work in solid pharmaceutical compositions has the potential to make a significant impact on the treatment of HCV. His innovative approach and collaborations with leading companies and professionals underscore his commitment to advancing healthcare solutions.